Natixis Advisors LLC Purchases 3,173 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Natixis Advisors LLC raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 21.5% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 17,946 shares of the medical instruments supplier’s stock after buying an additional 3,173 shares during the period. Natixis Advisors LLC’s holdings in DENTSPLY SIRONA were worth $447,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in XRAY. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. LRI Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at $32,000. Central Pacific Bank Trust Division acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $64,000. Finally, Mather Group LLC. bought a new position in DENTSPLY SIRONA in the 1st quarter valued at about $72,000. 95.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on XRAY shares. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Needham & Company LLC restated a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Stifel Nicolaus reduced their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Moderate Buy” and an average price target of $33.44.

Check Out Our Latest Analysis on XRAY

DENTSPLY SIRONA Price Performance

XRAY stock opened at $26.28 on Friday. The firm has a 50 day moving average of $25.36 and a 200-day moving average of $28.18. The firm has a market capitalization of $5.33 billion, a P/E ratio of -59.73, a price-to-earnings-growth ratio of 1.19 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a 12 month low of $23.58 and a 12 month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. DENTSPLY SIRONA’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.51 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.